| Number of medication-related problems identified |
30 (75%) |
| Number of medication-related problems resolved |
27 (67.5%) |
| Patient satisfaction |
26 (65%) |
| Patients meeting clinical goals (e.g., number of patients reaching hypertension, diabetes goals) compared to baseline |
22 (55%) |
| Clinician satisfaction |
14 (35%) |
| Reduction in hospital readmissions |
12 (30%) |
| Achievement of pay-for-performance measures |
8 (20%) |
| Total cost of care savings |
7 (17.5%) |
| Reduction in hospital admissions |
5 (12.5%) |
| Impact on medical providers (e.g., satisfaction, relative value units) |
5 (12.5%) |
| Return on investment |
5 (12.5%) |
| Medication cost impact (whether savings or increases in cost attributed to medications) |
4 (10%) |
| Change in medication adherence |
4 (10%) |
| Medication errors |
3 (7.5%) |
| Reduction in emergency room visits |
2 (5%) |
| Reduction in number of clinician visits |
1 (2.5%) |
| Change in ambulatory care resource utilization for defined groups of patients (e.g., walk-in appointment requests, phone calls to triage) |
0 (0%) |
| Our clinical/practice tracks clinical/financial goals, but we do not separate these out for patients receiving our CMM services versus others not receiving our services |
14 (35%) |
| I/we are not tracking any measures to describe CMM impact in this clinic. |
2 (5%) |
